Cargando…
In Silico and In Vitro Tailoring of a Chitosan Nanoformulation of a Human Metabolic Enzyme
Enzyme nanoencapsulation holds an enormous potential to develop new therapeutic approaches to a large set of human pathologies including cancer, infectious diseases and inherited metabolic disorders. However, enzyme formulation has been limited by the need to maintain the catalytic function, which i...
Autores principales: | Lino, Paulo R., Leandro, João, Amaro, Mariana, Gonçalves, Lídia M. D., Leandro, Paula, Almeida, António J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000282/ https://www.ncbi.nlm.nih.gov/pubmed/33806405 http://dx.doi.org/10.3390/pharmaceutics13030329 |
Ejemplares similares
-
Systematic Modification and Evaluation of Enzyme-Loaded Chitosan Nanoparticles
por: Lino, Paulo R., et al.
Publicado: (2021) -
Nematicidal Properties of Chitosan Nanoformulation
por: Mouniga, R., et al.
Publicado: (2023) -
Topical Administration of a Nanoformulation of Chitosan-Hyaluronic Acid-Epoetin Beta in a Rat Model of Glaucoma
por: Silva, Beatriz, et al.
Publicado: (2023) -
Design and Characterization of Chitosan Nanoformulations for the Delivery of Antifungal Agents
por: Calvo, Natalia L., et al.
Publicado: (2019) -
In vitro analysis of PARP inhibitor nanoformulations
por: Baldwin, Paige, et al.
Publicado: (2018)